medwireNews: Tenofovir disoproxil fumarate (TDF) treatment
results in viral suppression in Asian or Pacific Islander patients with
hepatitis B virus (HBV) infection, even if they have a high viral load,
an analysis shows.
It took longer for patients to achieve viral
suppression (HBV DNA <400 copies/mL) if they had a high viral load,
report Scott Fung (University of Toronto, Ontario, Canada) and
co-workers.
“However, delays in achieving virological suppression were not associated with adverse outcomes”, they write in Liver International.
Read more.... Labels: Asian Americans and Pacific Islanders (AAPIs), tenofovir, viral load, vrial suppression